piribedil has been researched along with Deafness in 2 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Deafness: A general term for the complete loss of the ability to hear from both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vergnon, L | 1 |
| Haguenauer, JP | 1 |
2 other studies available for piribedil and Deafness
| Article | Year |
|---|---|
[Study of trivastal in the cochleo-vestibular syndrome].
Topics: Deafness; Drug Evaluation; Humans; Meniere Disease; Piperazines; Piribedil; Vertigo | 1976 |
[Trivastan in otorhinolaryngology].
Topics: Adolescent; Adult; Aged; Deafness; Humans; Meniere Disease; Middle Aged; Otorhinolaryngologic Diseas | 1976 |